A detailed history of Us Bancorp \De\ transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 191 shares of CABA stock, worth $429. This represents 0.0% of its overall portfolio holdings.

Number of Shares
191
Previous 417 54.2%
Holding current value
$429
Previous $3,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$3.94 - $8.24 $890 - $1,862
-226 Reduced 54.2%
191 $0
Q2 2024

Aug 06, 2024

BUY
$7.22 - $18.82 $1,032 - $2,691
143 Added 52.19%
417 $3,000
Q4 2023

Feb 09, 2024

BUY
$12.21 - $23.36 $3,345 - $6,400
274 New
274 $6,000
Q4 2021

Feb 11, 2022

SELL
$3.36 - $14.64 $3,024 - $13,176
-900 Closed
0 $0
Q3 2020

Nov 10, 2020

BUY
$9.71 - $14.41 $5,826 - $8,646
600 Added 200.0%
900 $10,000
Q2 2020

Aug 07, 2020

BUY
$6.39 - $11.28 $1,917 - $3,384
300 New
300 $3,000

Others Institutions Holding CABA

About Cabaletta Bio, Inc.


  • Ticker CABA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,014,000
  • Market Cap $65.3M
  • Description
  • Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...
More about CABA
Track This Portfolio

Track Us Bancorp \De\ Portfolio

Follow Us Bancorp \De\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.